Loading...
Loading...
CHEK| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 0.0K |
| Gross Profit | 0.0K |
| Operating Expense | 3,409.5K |
| Operating I/L | -3,409.5K |
| Other Income/Expense | 253.5K |
| Interest Income | 0.0K |
| Pretax | -3,156.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -3,156.0K |
Check-Cap Ltd. is a clinical stage medical diagnostics company that develops a capsule-based screening technology using ultra-low-dose X-rays to scan the colon for precancerous polyps and structural abnormalities. Its C-Scan system includes the C-Scan Cap for polyp detection, C-Scan Track for data collection, and C-Scan View software for data analysis and report generation. The company generates revenue through the sale of its C-Scan system and related software, providing healthcare professionals with a non-invasive and patient-friendly solution for colon screening.
